Caroline D. Scatena
- Oncology top 10%
- Cancer-related Molecular Pathways 4
- Cell Biology top 10%
- Microtubule and mitosis dynamics 3
-
- Cancer therapeutics and mechanisms 3
- Cell death mechanisms and regulation 2
- Ubiquitin and proteasome pathways 2
-
- Stress Responses and Cortisol 3
- Toxicology top 10%
-
- Birth, Development, and Health 3
-
- Acute Myeloid Leukemia Research 1
Caroline D. Scatena
11 papers receiving 674 citations
Peers
Comparison fields: 5 of 76
- Oncology 335
- Cell Biology 129
- Molecular Biology 509
- Behavioral Neuroscience 23
- Toxicology 19
Countries citing papers authored by Caroline D. Scatena
This map shows the geographic impact of Caroline D. Scatena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline D. Scatena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline D. Scatena more than expected).
Fields of papers citing papers by Caroline D. Scatena
This network shows the impact of papers produced by Caroline D. Scatena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline D. Scatena. The network helps show where Caroline D. Scatena may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Caroline D. Scatena, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 43 | |
| 2 | SNS-595 potentiates the in vivo antitumor activity of carboplatin, cisplatin, and gemcitabine in solid tumor xenografts. | 2007 | 3 |
| 3 | 2005 | 0 | |
| 4 | 2004 | 58 | |
| 5 | A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors. | 2001 | 60 |
| 6 | 2000 | 71 | |
| 7 | 2000 | 144 | |
| 8 | 1998 | 202 | |
| 9 | 1998 | 8 | |
| 10 | Negative regulation of Wee1 expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis. | 1998 | 62 |
| 11 | 1998 | 23 | |
| 12 | 1996 | 22 |
About Caroline D. Scatena
Caroline D. Scatena is a scholar working on Behavioral Neuroscience, Pharmacy and Cell Biology, having authored 12 papers that have together received 696 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Cancer therapeutics and mechanisms (3 papers), Stress Responses and Cortisol (3 papers), Birth, Development, and Health (3 papers), Microtubule and mitosis dynamics (3 papers), Cell death mechanisms and regulation (2 papers), Ubiquitin and proteasome pathways (2 papers) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Oncology (335 citations), Cell Biology (129 citations) and Molecular Biology (509 citations). Caroline D. Scatena has collaborated with scholars based in United States. Frequent co-authors include Jennifer A. Pietenpol, Christopher J. Keefer, Steven D. Leach, Patricia M. Flatt, Deborah J. Mays, Suzanne Szak, Zoe A. Stewart, Stuart B. Adler, Liying Yang and Si Young Song. Their work appears in journals such as Journal of Biological Chemistry, Blood and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.